港股详情

本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

药捷安康-B

193.400

+1.3000.68%

成交量：51.20万

成交额：1.04亿

市值：767.80亿

市盈率：-246.42

高：210.000

开：198.800

低：192.500

收：192.000

52周最高：679.500

52周最低：20.200

股本：3.97亿

香港流通股本：3.02亿

量比：4.22

换手率：0.17%

股息：- -

股息率：- -

每股收益(LYR):-0.785

净资产收益率：-39.08%

总资产收益率：-21.10%

市净率：120.91

市盈率(LYR):-246.42

市销率: - -

数据加载中...

总览公司新闻公告

药捷安康低开高走涨近50%，创上市以来新高

老虎资讯综合

港股午评|恒生指数早盘涨0.29% CRO概念股走高

港股异动 | 药捷安康(02617.HK)早盘重挫18% 总市值不足700亿港元上半年集团未取得主营业务收入

0营收还亏损1.23亿元，61岁南大校友掌舵的港股药企，凭什么撑起700亿市值

一则临床进展公告拉动480亿港元市值！创新药“十倍股”药捷安康的“临床故事”，真有这么高含金量？

每日经济新闻

上半年营收为0，亏损1.23亿元，药捷安康股价一天大涨77%，市值达764亿港元

每日经济新闻

刷屏！暴涨超130% 发生了什么？

海外消费周报：关注高教政策推进办学投入拐点显现经营效率提升可期

申万宏源研究

药捷安康盘中上涨超120%，市值逼近千亿港元核心管线替恩戈替尼刚获批一项临床试验

每日经济新闻

港股异动 | 药捷安康-B(02617.HK)尾盘回落收涨77.09% 全天成交额超26亿港元换手率约4.74%

港股异动 | 药捷安康-B(02617.HK)午后涨近88% 较招股价已涨超14倍总市值一度突破800亿港元

药捷安康-B日内涨幅扩大逾120%！该股自上市以来累涨逾1600%

老虎资讯综合

港股异动 | 药捷安康-B(02617.HK)再涨超18% 总市值突破500亿港元替恩戈替尼乳癌II期试验获批

《全日速报》恒指全日收报26,086点跌113点; 恒生科技指数全日收报5,888点跌13点美团跌逾5% 万洲、紫金矿业、汇控、周大福、药捷安康－Ｂ创新高成交畅旺

阿斯达克财经

港股异动 | 药捷安康-B(02617.HK)再涨超15% 总市值突破400亿港元替恩戈替尼II期临床试验获批开展

药捷安康-B股价再刷上市以来新高！核心产品II期临床试验获批开展

老虎资讯综合

药捷安康-B(02617)：替恩戈替尼联合氟维司群治疗经治失败的HR阳性╱HER2阴性或低表达的复发或转移性乳腺癌II期临床试验获批开展

Transthera Sciences (Nanjing) Inc获得NMPA批准开展替尼诺替尼联合疗法II期试验

港股收盘恒生指数涨1.01%恒生科技指数涨1.27%。港股科技ETF（159751）涨0.43%恒生港股通ETF（159

迈博药业-B盘中异动下午盘快速拉升6.41%报0.830港元

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/stock/02617/news?page=5"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"02617","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02617\",,,,,undefined,":{"symbol":"02617","market":"HK","secType":"STK","nameCN":"药捷安康-B","latestPrice":193.3,"timestamp":1761183250984,"preClose":192,"halted":0,"volume":511501,"delay":0,"floatShares":301666673,"shares":397000000,"eps":-0.7848470656843544,"marketStatus":"交易中","change":1.3,"latestTime":"10-23 09:34:11","open":198.8,"high":210,"low":192.5,"amount":103538492,"amplitude":0.091146,"askPrice":194,"askSize":3000,"bidPrice":193.3,"bidSize":500,"shortable":0,"etf":0,"ttmEps":-0.6770826891106343,"tradingStatus":2,"nextMarketStatus":{"tag":"午间休市","tradingStatus":4,"beginTime":1761192000000},"marketStatusCode":2,"adr":0,"listingDate":1750608000000,"exchange":"SEHK","adjPreClose":192,"openAndCloseTimeList":[[1761183000000,1761192000000],[1761195600000,1761206400000]],"volumeRatio":4.213728,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02617\",,,,,undefined,":{"symbol":"02617","floatShares":301666673,"roa":"-21.10%","roe":"-39.08%","lyrEps":-0.784847,"volumeRatio":4.217847,"shares":397000000,"dividePrice":0,"high":210,"amplitude":0.091146,"preClose":192,"low":192.5,"week52Low":20.2,"pbRate":"120.91","week52High":679.5,"institutionHeld":0,"latestPrice":193.4,"committee":-0.714286,"eps":-0.7848470656843544,"divideRate":0,"volume":512001,"delay":0,"ttmEps":-0.6770826891106343,"open":198.8,"prevYearClose":13.15,"prevWeekClose":203,"prevMonthClose":141.2,"prevQuarterClose":141.2,"fiveDayClose":166.1,"twentyDayClose":165.1,"sixtyDayClose":40.9},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/02617\",params:#limit:5,,,undefined,":[{"date":"2025-08-25","symbol":"02617","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1756085400000,"name":null,"time":"","dateTimestamp":1756051200000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"02617\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"02617\",market:\"HK\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/02617\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"02617","date":"2025-10-21","current":-283.620572,"percent":0.035714,"low":-380.446233,"twenty":-184.903189,"median":-58.041658,"eighty":-41.987471,"high":-17.403134,"avg":-102.901877,"sd":82.505554,"marketCap":68544221219},"quantilePoints":[{"date":"2025-06-20","current":-17.403134,"twenty":-17.403134,"median":-17.403134,"eighty":-17.403134,"marketCap":5219203873},{"date":"2025-06-27","current":-36.622688,"twenty":-34.709071,"median":-32.493198,"eighty":-31.066553,"marketCap":11013909315},{"date":"2025-07-04","current":-44.802949,"twenty":-38.622694,"median":-35.660049,"eighty":-31.776499,"marketCap":13474674640},{"date":"2025-07-11","current":-39.630155,"twenty":-40.38446,"median":-38.336544,"eighty":-32.816725,"marketCap":11906928990},{"date":"2025-07-18","current":-43.957869,"twenty":-42.111612,"median":-39.630155,"eighty":-34.373739,"marketCap":13196846297},{"date":"2025-07-25","current":-49.067594,"twenty":-42.195906,"median":-40.285196,"eighty":-36.230637,"marketCap":14784436829},{"date":"2025-08-01","current":-50.963195,"twenty":-45.655878,"median":-41.371359,"eighty":-36.620356,"marketCap":15260713988},{"date":"2025-08-08","current":-58.015216,"twenty":-51.234741,"median":-42.017389,"eighty":-37.993773,"marketCap":17415868136},{"date":"2025-08-15","current":-66.867935,"twenty":-57.065221,"median":-42.261724,"eighty":-38.707864,"marketCap":20043330466},{"date":"2025-08-22","current":-72.723484,"twenty":-59.09189,"median":-43.957869,"eighty":-39.464263,"marketCap":21730145406},{"date":"2025-08-29","current":-49.610789,"twenty":-64.458089,"median":-47.896219,"eighty":-39.630155,"marketCap":21492006826},{"date":"2025-09-05","current":-57.867887,"twenty":-63.405379,"median":-50.300475,"eighty":-39.739866,"marketCap":25044240642},{"date":"2025-09-12","current":-176.221101,"twenty":-67.557018,"median":-51.642061,"eighty":-40.181616,"marketCap":76402794352},{"date":"2025-09-19","current":-137.321051,"twenty":-71.134174,"median":-54.042597,"eighty":-40.68225,"marketCap":59494955186},{"date":"2025-09-26","current":-219.814439,"twenty":-72.736767,"median":-55.62397,"eighty":-41.23574,"marketCap":56835741045},{"date":"2025-10-03","current":-208.418403,"twenty":-113.88308,"median":-57.213624,"eighty":-41.375772,"marketCap":54017767851},{"date":"2025-10-10","current":-183.264838,"twenty":-172.633767,"median":-57.790453,"eighty":-41.583173,"marketCap":47429267143},{"date":"2025-10-17","current":-311.562728,"twenty":-178.967921,"median":-58.015216,"eighty":-41.927636,"marketCap":80570219499},{"date":"2025-10-21","current":-264.885138,"twenty":-184.903189,"median":-58.041658,"eighty":-41.987471,"marketCap":68544221219}],"updateTime":1761152557609},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"02617\",pageSize:20,pageCount:5,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1138498450","title":"药捷安康低开高走涨近50%，创上市以来新高","url":"https://stock-news.laohu8.com/highlight/detail?id=1138498450","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1138498450?lang=zh_cn&edition=fundamental","pubTime":"2025-09-15 13:16","pubTimestamp":1757913398,"startTime":"0","endTime":"0","summary":"9月15日（周一），药捷安康低开高走涨近50%，创上市以来新高，前7个交易日狂飙逾360%！","market":"us","thumbnail":"https://static.tigerbbs.com/d17cb0ea313437e7afb8bad7f25dce9a","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/d17cb0ea313437e7afb8bad7f25dce9a"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"5144c09c2993e0c7de4c76f1c2196293","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02617"],"gpt_icon":0},{"id":"2567167035","title":"港股午评|恒生指数早盘涨0.29%    CRO概念股走高","url":"https://stock-news.laohu8.com/highlight/detail?id=2567167035","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2567167035?lang=zh_cn&edition=fundamental","pubTime":"2025-09-15 12:00","pubTimestamp":1757908804,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，港股恒生指数涨0.29%，涨75点，报26463点；恒生科技指数涨1.11%。港股早盘成交1620亿港元。药捷安康再涨超33%，药捷安康被调入港股通标的名单，自9月8日起生效。锂电池板块涨幅居前，大摩发研报唱好宁德时代，机构称市场关注锂电明年需求预期。沪上阿姨涨超8%，公司近期获纳入港股通名单，上半年门店数量平稳增长。9月8日起，脑动极光正式获纳入港股通名单。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1345108.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["06681","HSImain","02833","02617","513600","BK1584","159271","HHImain","HSCEI","HSI","BK4614","YANG","MHImain","HSTECH","00376","BK1161","BK1501","BK1184","BK1189","MCHmain"],"gpt_icon":1},{"id":"2567016177","title":"港股异动 | 药捷安康(02617.HK)早盘重挫18% 总市值不足700亿港元 上半年集团未取得主营业务收入","url":"https://stock-news.laohu8.com/highlight/detail?id=2567016177","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2567016177?lang=zh_cn&edition=fundamental","pubTime":"2025-09-15 10:07","pubTimestamp":1757902056,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["02617","BK1161"],"gpt_icon":0},{"id":"2567565561","title":"0营收还亏损1.23亿元，61岁南大校友掌舵的港股药企，凭什么撑起700亿市值","url":"https://stock-news.laohu8.com/highlight/detail?id=2567565561","media":"鱼禾财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2567565561?lang=zh_cn&edition=fundamental","pubTime":"2025-09-14 19:07","pubTimestamp":1757848039,"startTime":"0","endTime":"0","summary":"没有主营收入还亏损1.23亿元靠一款创新药持续发力虽然在港股一路狂飙、市值一度逼近千亿，但与大多数生物科技公司一样，药捷安康目前还没有商业化产品，业绩处在亏损中。今年上半年，药捷安康依旧没有主营业务收入，其他收入及收益由2024年的1040万元下降至360万元，降幅达65.1%。此外，药捷安康上半年录得税前亏损1.23亿元，相较于2024年同期亏损的1.6亿元有所改善。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025091419203597913440&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025091419203597913440&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["HSTECH","02617","HSCEI"],"gpt_icon":1},{"id":"2567115584","title":"一则临床进展公告拉动480亿港元市值！创新药“十倍股”药捷安康的“临床故事”，真有这么高含金量？","url":"https://stock-news.laohu8.com/highlight/detail?id=2567115584","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2567115584?lang=zh_cn&edition=fundamental","pubTime":"2025-09-14 18:13","pubTimestamp":1757844789,"startTime":"0","endTime":"0","summary":"截至当日收盘，药捷安康总市值达到764亿港元，排在港股创新药板块第12位。公司股价近期的上涨，起始于9月10日披露核心产品替恩戈替尼一项临床试验获得临床默示许可的公告，此后3个交易日，市值激增近480亿港元。一则公告拉动480亿港元市值？获得该许可，意味着经过60个公示日后，药捷安康可以按照提交的方案启动II期临床试验。9月14日，药捷安康相关人士表示，暂时不方便接受采访。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250914181615a4c5721a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250914181615a4c5721a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02617","BK1574","06978","BK1161"],"gpt_icon":1},{"id":"2567189312","title":"上半年营收为0，亏损1.23亿元，药捷安康股价一天大涨77%，市值达764亿港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2567189312","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2567189312?lang=zh_cn&edition=fundamental","pubTime":"2025-09-13 12:51","pubTimestamp":1757739060,"startTime":"0","endTime":"0","summary":"炒股就看金麒麟分析师研报，权威，专业，及时，全面，助您挖掘潜力主题机会！　　9月12日开盘，药捷安康一路上涨，盘中最高达到251.40港元/股，涨幅超130%，总市值一度逼近千亿港元，截至当日收盘，公司股价大涨77%，市值为764.03亿港元。　　与多数Biotech一样，药捷安康目前还没有商业化产品，今年上半年，公司的营业收入为0，亏损1.23亿元，公司主要管线包括6款临床阶段候选产品及多款临床前阶段候选产品，其中，替恩戈替尼是核心产品。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/jjxw/2025-09-13/doc-infqimam6745467.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/jjxw/2025-09-13/doc-infqimam6745467.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["02617"],"gpt_icon":0},{"id":"2567900646","title":"刷屏！暴涨超130% 发生了什么？","url":"https://stock-news.laohu8.com/highlight/detail?id=2567900646","media":"券商中国","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2567900646?lang=zh_cn&edition=fundamental","pubTime":"2025-09-13 07:25","pubTimestamp":1757719546,"startTime":"0","endTime":"0","summary":"一只港股次新股刷屏了！9月12日，药捷安康-B(02617.HK)午后持续冲高，盘中一度涨超130%，最近3个交易日，涨幅达2倍。该股上市还不到3个月时间，股价已飙升超18倍，市值一度达到997亿港元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202509133512702444.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["02617","BK1161"],"gpt_icon":1},{"id":"2567018205","title":"海外消费周报：关注高教政策推进 办学投入拐点显现 经营效率提升可期","url":"https://stock-news.laohu8.com/highlight/detail?id=2567018205","media":"申万宏源研究","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2567018205?lang=zh_cn&edition=fundamental","pubTime":"2025-09-13 00:00","pubTimestamp":1757692800,"startTime":"0","endTime":"0","summary":"过去5 年民办高校办学投入持续增长，经营效益持续恶化。因此收入增速持续放缓。伴随办学投入及资本开支见顶，高教公司派息恢复也值得期待。营利性政策的推进，将保障高校公司对办学收益的分配权益。研究结果显示，在137 例既往接受过治疗的ES-SCLC 患者中，ORR 为48.2%、DCR 为87.6%、mPFS为4.9 个月、mOS 为10.3 个月。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250913202056978f8153&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250913202056978f8153&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["00013","BK1161","02617","02001"],"gpt_icon":1},{"id":"2566977105","title":"药捷安康盘中上涨超120%，市值逼近千亿港元 核心管线替恩戈替尼刚获批一项临床试验","url":"https://stock-news.laohu8.com/highlight/detail?id=2566977105","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2566977105?lang=zh_cn&edition=fundamental","pubTime":"2025-09-12 22:16","pubTimestamp":1757686615,"startTime":"0","endTime":"0","summary":"每经记者｜林姿辰    每经编辑｜魏官红9月12日开盘，药捷安康一路上涨，盘中最高达到251.40港元/股，总市值一度逼近千亿港元，截至当日收盘，公司市值为764.03亿港元。截至6月30日，替恩戈替尼在全球已进行或正在进行共9项公司发起的临床试验，其中2项临床试验在健康受试者中进行，7项临床试验在实体瘤患者中进行。不过，2023年，LG Chem与药捷安康同意终止该对外授权安排，招股书中并未披露终止原因。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250912221724a4c2ea3f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":"07d006678791573abfcbda7f1d8c4a2f","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250912221724a4c2ea3f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02617","BK1161"],"gpt_icon":1},{"id":"2566921601","title":"港股异动 | 药捷安康-B(02617.HK)尾盘回落收涨77.09% 全天成交额超26亿港元 换手率约4.74%","url":"https://stock-news.laohu8.com/highlight/detail?id=2566921601","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2566921601?lang=zh_cn&edition=fundamental","pubTime":"2025-09-12 16:10","pubTimestamp":1757664612,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"07d006678791573abfcbda7f1d8c4a2f","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK1161","02617"],"gpt_icon":0},{"id":"2566940744","title":"港股异动 | 药捷安康-B(02617.HK)午后涨近88% 较招股价已涨超14倍 总市值一度突破800亿港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2566940744","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2566940744?lang=zh_cn&edition=fundamental","pubTime":"2025-09-12 13:39","pubTimestamp":1757655563,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"07d006678791573abfcbda7f1d8c4a2f","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK1161","02617"],"gpt_icon":0},{"id":"1109419271","title":"药捷安康-B日内涨幅扩大逾120%！该股自上市以来累涨逾1600%","url":"https://stock-news.laohu8.com/highlight/detail?id=1109419271","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1109419271?lang=zh_cn&edition=fundamental","pubTime":"2025-09-12 13:17","pubTimestamp":1757654231,"startTime":"0","endTime":"0","summary":"9月12日，$药捷安康-B(02617)$盘初再飙逾18%，股价续刷上市以来新高，总市值突破500亿港元。","market":"hk","thumbnail":"https://static.tigerbbs.com/fb4be1ff4aaa40ac88564f80f173158e","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/fb4be1ff4aaa40ac88564f80f173158e"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"07d006678791573abfcbda7f1d8c4a2f","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":"药捷安康-B股价续刷新高，上市以来累涨逾1200%","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02617"],"gpt_icon":0},{"id":"2566949544","title":"港股异动 | 药捷安康-B(02617.HK)再涨超18% 总市值突破500亿港元 替恩戈替尼乳癌II期试验获批","url":"https://stock-news.laohu8.com/highlight/detail?id=2566949544","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2566949544?lang=zh_cn&edition=fundamental","pubTime":"2025-09-12 09:57","pubTimestamp":1757642264,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"07d006678791573abfcbda7f1d8c4a2f","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["02617","BK1161"],"gpt_icon":0},{"id":"2566685229","title":"《全日速报》恒指全日收报26,086点 跌113点; 恒生科技指数全日收报5,888点 跌13点 美团跌逾5% 万洲、紫金矿业、汇控、周大福、药捷安康－Ｂ创新高 成交畅旺","url":"https://stock-news.laohu8.com/highlight/detail?id=2566685229","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2566685229?lang=zh_cn&edition=fundamental","pubTime":"2025-09-11 16:12","pubTimestamp":1757578320,"startTime":"0","endTime":"0","summary":"恒指全日收26,086点，跌113点或0.4%。恒生科技指数报5,888点，跌13点或0.2%。国指跌67点或0.7%，报9,260点。大市成交额3,252.05亿元。沽空资料截至 2025-09-11 16:25。","market":"fut","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180725103754138_s.png","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180725103754138_s.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1469686/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["601899","LU0348814723.USD","HSI","HSHD.SI","HK0000320264.USD","LU1807302812.USD","02617","LU0463099449.HKD","LU1008478684.HKD","SG9999002463.SGD","SG9999002562.SGD","LU0572944931.SGD","LU1831875114.USD","03143","LU0210526637.USD","HHImain","LU0828237510.HKD","HSBA.UK","00005","LU0049853897.USD","LU0370786039.SGD","LU0737861699.HKD","02833","HSImain","BK0077","03690","LU0011963245.USD","LU0611395673.USD","IE0008369823.USD","HSBC","LU1282648689.USD","METmain","LU0039217434.USD","LU0048580855.USD","LU2045819591.USD","LU1048588211.SGD","HMTD.SI","HSTECH","SG9999001903.USD","LU0531971595.HKD","513600","LU0348816934.USD","LU2148510915.USD","02899","BK1610","LU0868486357.SGD","MHImain","01929","MPNGY","MCHmain"],"gpt_icon":0},{"id":"2566376699","title":"港股异动 | 药捷安康-B(02617.HK)再涨超15% 总市值突破400亿港元 替恩戈替尼II期临床试验获批开展","url":"https://stock-news.laohu8.com/highlight/detail?id=2566376699","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2566376699?lang=zh_cn&edition=fundamental","pubTime":"2025-09-11 10:50","pubTimestamp":1757559047,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"603793f027d63040f5e30da5bde0c993","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["02617","BK1161"],"gpt_icon":0},{"id":"1131617722","title":"药捷安康-B股价再刷上市以来新高！核心产品II期临床试验获批开展","url":"https://stock-news.laohu8.com/highlight/detail?id=1131617722","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1131617722?lang=zh_cn&edition=fundamental","pubTime":"2025-09-11 10:44","pubTimestamp":1757558663,"startTime":"0","endTime":"0","summary":"9月11日，$药捷安康-B$盘中强势拉升，现涨近18%，股价再刷上市以来新高。药捷安康-B公布，公司核心产品替恩戈替尼联合氟维司群治疗经治失败的激素受体阳性(HR+)且人表皮生长因子受体2阴性或低表达的复发或转移性乳腺癌II期临床试验，已于2025年9月 10日获得了中国国家药品监督管理局的临床默示许可。临床前实验结果表明，替恩戈替尼与氟维司群的联合用药针对内分泌治疗耐药的乳腺癌细胞具有药理学协同作用。","market":"hk","thumbnail":"https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"603793f027d63040f5e30da5bde0c993","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":"药捷安康-B股价再刷上市以来新高！核心产品II期临床试验获批开展","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02617"],"gpt_icon":0},{"id":"2566668602","title":"药捷安康-B(02617)：替恩戈替尼联合氟维司群治疗经治失败的HR阳性╱HER2阴性或低表达的复发或转移性乳腺癌II期临床试验获批开展","url":"https://stock-news.laohu8.com/highlight/detail?id=2566668602","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2566668602?lang=zh_cn&edition=fundamental","pubTime":"2025-09-10 21:50","pubTimestamp":1757512252,"startTime":"0","endTime":"0","summary":"本试验为在中国开展的一项评价替恩戈替尼片联合氟维司群注射液用于经治失败的HR+/HER2-的复发或转移性乳腺癌患者的安全性、疗效及药代动力学的开放标签、多中心、II期临床研究。临床前实验结果表明，替恩戈替尼与氟维司群的联合用药针对内分泌治疗耐药的乳腺癌细胞具有药理学协同作用。因此替恩戈替尼联合氟维司群的临床治疗策略将可能为此类乳腺癌患者的治疗带来新的突破。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1343826.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","02617","BK4225","BK4203","HR"],"gpt_icon":1},{"id":"1180858364","title":"Transthera Sciences (Nanjing) Inc获得NMPA批准开展替尼诺替尼联合疗法II期试验","url":"https://stock-news.laohu8.com/highlight/detail?id=1180858364","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1180858364?lang=zh_cn&edition=fundamental","pubTime":"2025-09-10 21:49","pubTimestamp":1757512161,"startTime":"0","endTime":"0","summary":"Transthera Sciences (Nanjing) Inc（药捷安康-B）已获得国家药品监督管理局(NMPA)批准，可开展替尼诺替尼联合疗法的II期临床试验。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02617","BK1161"],"gpt_icon":0},{"id":"2566675070","title":"港股收盘恒生指数涨1.01%恒生科技指数涨1.27%。港股科技ETF（159751）涨0.43%恒生港股通ETF（159","url":"https://stock-news.laohu8.com/highlight/detail?id=2566675070","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2566675070?lang=zh_cn&edition=fundamental","pubTime":"2025-09-10 16:10","pubTimestamp":1757491806,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LU1282649067.USD","LU0244354667.USD","JD","LU1481107354.HKD","BK4504","LU0871576103.HKD","LNVGY","IE0034224299.USD","513600","CFA.SI","SUHJY","HSTECH","159837","02617","03145","02833","02473","IE0032431581.USD","09618","HHImain","YANG","00016","REIT","80992","LU0499858438.USD","HSCEI","LU2088748020.USD","MCHmain","LU0594300419.USD","01530","LU0307460666.USD","00992","80016","07226","513020","BK4585","159751","159271","LU1188198961.HKD","MHImain","159318","LU0348735423.USD","09678","89618","513990","LU0488056044.USD","HSI","03121","159227","HSImain"],"gpt_icon":0},{"id":"2566763106","title":"迈博药业-B盘中异动 下午盘快速拉升6.41%报0.830港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2566763106","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2566763106?lang=zh_cn&edition=fundamental","pubTime":"2025-09-10 13:30","pubTimestamp":1757482248,"startTime":"0","endTime":"0","summary":"2025年09月10日下午盘13时30分，迈博药业-B股票出现波动，股价快速上涨6.41%。截至发稿，该股报0.830港元/股，成交量36.2万股，换手率0.01%，振幅10.26%。资金方面，该股资金流入1660港元，流出27.652万港元。迈博药业-B股票所在的生物技术行业中，整体涨幅为0.02%。迈博药业-B公司简介：迈博药业有限公司是一家主要从事癌症及自身免疫性疾病的单抗药物的研究、开发及生产的投资控股公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025091013304895203c87&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025091013304895203c87&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02617","02181","BK1574","06628","02257","BK1161"],"gpt_icon":0}],"pageSize":20,"totalPage":9,"pageCount":5,"totalSize":180,"code":"91000000","status":"200"}]}}